Our pan-cancer analysis demonstrates that the cuproptosis-regulatory gene SLC31A1 is dysregulated in various cancers with its expression and genetic alteration associated with clinical outcomes in patients with these tumors. This evidence concerns the gene SLC31A1 and cancer.